Design and synthesis of sodium (beta R*, gamma S*)-4-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl] thio]-gamma-hydroxy-beta-methylbenzenebutanoate: a novel, selective, and orally active receptor antagonist of leukotriene D4.
D000818:Animals; D001681:Biological Assay; D001980:Bronchi / Q000502:physiology; D055598:Chemical Phenomena; D002621:Chemistry; D006168:Guinea Pigs; D007082:Ileum / Q000502:physiology; D009119:Muscle Contraction / Q000187:drug effects; D010654:Phenylbutyrates / Q000138:chemical synthesis / Q000494:pharmacology*; D013189:SRS-A / Q000037:antagonists & inhibitors*; D014132:Trachea / Q000502:physiology
D010654:Phenylbutyrates; D013189:SRS-A; C050033:L 649923